News
FSNUY
13.56
-0.07%
-0.01
DZ BANK AG Remains a Buy on Fresenius SE & Co. KGaA (0OO9)
TipRanks · 1d ago
Fresenius SE price target raised to EUR 52 from EUR 49 at Morgan Stanley
TipRanks · 1d ago
Fresenius SE & Co. KGaA (0OO9) Gets a Buy from Morgan Stanley
TipRanks · 1d ago
Weekly Report: what happened at FSNUY last week (0803-0807)?
Weekly Report · 1d ago
Fresenius SE price target lowered to EUR 55.20 from EUR 56.60 at JPMorgan
TipRanks · 5d ago
Fresenius SE price target raised to EUR 56 from EUR 55 at Deutsche Bank
TipRanks · 5d ago
Deutsche Bank Sticks to Their Buy Rating for Fresenius SE & Co. KGaA (0OO9)
TipRanks · 5d ago
Barclays Sticks to Their Buy Rating for Fresenius SE & Co. KGaA (0OO9)
TipRanks · 6d ago
Fresenius SE Earnings Call Signals Confident Upswing
TipRanks · 6d ago
J.P. Morgan Reaffirms Their Buy Rating on Fresenius SE & Co. KGaA (0OO9)
TipRanks · 6d ago
Jefferies Remains a Buy on Fresenius SE & Co. KGaA (0OO9)
TipRanks · 08/05 07:25
Fresenius announces FDA approval of rituximab biosimilar
TipRanks · 08/03 20:15
Weekly Report: what happened at FSNUY last week (0727-0731)?
Weekly Report · 08/03 10:21
Fresenius announces FDA, EMA acceptance of vedolizumab biosimilar for review
TipRanks · 07/31 11:11
Weekly Report: what happened at FSNUY last week (0720-0724)?
Weekly Report · 07/27 10:26
Shares in Generic-Drug Makers Fall After Trump's Tariff Plan
Dow Jones · 07/22 10:34
Fresenius SE & Co. KGaA (0OO9) Gets a Buy from Jefferies
TipRanks · 07/21 22:11
Fresenius SE price target raised to EUR 49 from EUR 48 at Morgan Stanley
TipRanks · 07/21 19:35
Weekly Report: what happened at FSNUY last week (0713-0717)?
Weekly Report · 07/20 10:22
Deutsche Bank Reaffirms Their Buy Rating on Fresenius SE & Co. KGaA (0OO9)
TipRanks · 07/20 08:27
More
Webull provides a variety of real-time FSNUY stock news. You can receive the latest news about Fresenius through multiple platforms. This information may help you make smarter investment decisions.
About FSNUY
Fresenius SE & Co KGaA is a Germany-based healthcare company. The Company has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.